Feedback

US regulator warns of rare side effect on Johnson & Johnson's vaccine

Source : 112 Ukraine

Symptoms include mild bruising or tiny blood spots under the skin, as well as excessive bleeding
12:11, 12 January 2022

Open source

The US Food and Drug Administration (FDA) has amended information about the Johnson & Johnson vaccine. A rare risk of immune thrombocytopenia, particularly bleeding, has been added as Reuters reported.

"Reports of adverse events following use of the Janssen COVID-19 vaccine under emergency use authorization suggest an increased risk of immune thrombocytopenia during the 42 days following vaccination," the regulator said.

Related: No increase in side effects after booster dose vaccination, - Ukrainian Health Ministry

It should be noted that Johnson & Johnson and AstraZeneca vaccines based on a similar platform have previously been linked to another rare combination of blood clotting and low platelet counts, known as thrombosis with thrombocytopenia syndrome.

We remind that the European Union's regulatory body, the European Medicines Agency (EMA), doubts the need for a fourth booster dose of the Covid-19 vaccine.

 

 

Topics:
Система Orphus

If you find an error, highlight the desired text and press Ctrl + Enter, to tell about it

Comments
see more
latest news
editor's choice
video